Understanding Pulmonary Hypertension Causes, Symptoms, Treatments

Pulmonary hypertension is a chronic condition that affects the blood vessels between the heart and lungs, gradually increasing pressure in these arteries and making it harder for the heart to pump blood forward. Over time, this extra workload can weaken the heart and limit a person’s ability to perform everyday activities.

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.

What is pulmonary hypertension and how it affects heart

Pulmonary hypertension refers to abnormally high blood pressure in the pulmonary arteries, the vessels that carry blood from the right side of the heart to the lungs. It is different from more familiar forms of hypertension that affect the systemic arteries in the rest of the body.

When the pressure in these lung arteries rises, the right ventricle must pump harder to move blood through narrowed or stiffened vessels. Over time, the right ventricle can become enlarged and less efficient, a condition called right heart failure. Because the lungs receive less blood flow, oxygen exchange can also be reduced, leading to shortness of breath and fatigue even with routine activities.

Pulmonary hypertension is not a single disease but a group of related conditions. Specialists often classify it into categories based on the underlying cause, such as disease of the pulmonary arteries themselves, heart conditions on the left side of the heart, chronic lung disease, or chronic blood clots in the lungs. Understanding which group a person belongs to strongly influences management decisions.

Causes and risk factors of pulmonary hypertension in US

In the United States, pulmonary hypertension can arise from a range of medical problems. In some people, no clear cause is found, a form known as idiopathic pulmonary arterial hypertension. Others may have heritable forms linked to gene variants that affect blood vessel function.

Common associated conditions include connective tissue diseases (such as scleroderma or lupus), certain types of congenital heart disease, chronic liver disease, and HIV infection. Long-term use of some appetite-suppressant medications in the past was also linked to pulmonary arterial hypertension. Chronic obstructive pulmonary disease (COPD), interstitial lung diseases, and sleep-disordered breathing, including obstructive sleep apnea, can lead to elevated pressure in the lung circulation over time.

Risk factors include a family history of pulmonary arterial hypertension, certain genetic variants, autoimmune diseases, liver disease, prior blood clots in the lungs, and living at high altitude for extended periods. Some patients are more commonly affected at younger adult ages, while others develop pulmonary hypertension later in life as part of broader heart or lung disease. Because different causes require different treatment approaches, clinicians focus carefully on identifying any underlying condition.

Recognizing the symptoms of pulmonary hypertension

Symptoms often develop gradually and can be subtle early on, which is one reason pulmonary hypertension may go unrecognized for months or even years. Shortness of breath with exertion is one of the most common early complaints. People may notice they cannot walk as far as they used to, or that climbing stairs leaves them unusually winded.

Fatigue, weakness, and decreased exercise tolerance are also frequent. Some individuals experience chest discomfort or pressure, a racing or irregular heartbeat (palpitations), dizziness, or episodes of near-fainting or fainting, especially during activity. As the condition progresses, fluid can build up in the legs, ankles, or abdomen, causing swelling and a feeling of fullness.

Because these symptoms overlap with those of asthma, deconditioning, anxiety, or coronary artery disease, they can be mistaken for other issues. Persistent or worsening shortness of breath, particularly when it is out of proportion to a person’s usual level of activity, is an important signal for clinical evaluation.

Diagnosis of pulmonary hypertension in US clinics

In clinical settings across the United States, diagnosis typically begins with a detailed medical history and physical examination. A clinician will ask about symptoms, exercise capacity, family history, other medical conditions, medications, and possible exposures. On examination, they look for signs such as leg swelling, enlarged neck veins, changes in heart sounds, or fluid in the lungs.

Several tests help evaluate the heart and lungs. A transthoracic echocardiogram (heart ultrasound) is usually a key early test. It can estimate pressures inside the heart and pulmonary arteries and assess the size and function of the right ventricle. Electrocardiograms (ECG), chest X-rays, and blood tests provide additional clues about heart strain or associated diseases.

Lung-focused tests may include pulmonary function tests to assess airflow and lung volumes, imaging such as a ventilation–perfusion (V/Q) scan to look for chronic blood clots, and computed tomography (CT) scans to evaluate lung structure and blood vessels. In many cases, a right heart catheterization is performed. During this procedure, a thin catheter is guided through a vein into the right side of the heart and pulmonary arteries to directly measure pressures and oxygen levels. This is considered the definitive test for confirming pulmonary hypertension and helps guide specific therapy.

Medical treatments for pulmonary hypertension

Treatment strategies in the United States depend on the type and severity of pulmonary hypertension and any underlying conditions. For some patients, managing an associated problem—such as optimizing therapy for left-sided heart failure, treating lung disease, or addressing chronic blood clots—can improve pulmonary pressures and symptoms.

For pulmonary arterial hypertension, several medication classes target the blood vessels in the lungs. Endothelin receptor antagonists help relax and remodel pulmonary arteries. Phosphodiesterase-5 inhibitors and soluble guanylate cyclase stimulators support pathways that widen blood vessels and reduce pressure. Prostacyclin analogs and related therapies act as powerful vasodilators and can be delivered intravenously, subcutaneously, by inhalation, or orally, depending on the specific drug and disease severity.

Additional supportive treatments may include diuretics to manage fluid retention, supplemental oxygen for people with low oxygen levels, and in some cases anticoagulants (blood thinners) when blood clot risk is high. Structured exercise programs, tailored to the individual and supervised by medical teams, can improve functional capacity for many patients. In advanced or treatment-resistant cases, procedures such as atrial septostomy or lung transplantation may be considered in specialized centers.

Because pulmonary hypertension is complex and may progress over time, ongoing follow-up with clinicians experienced in this condition is important. Regular assessment of symptoms, exercise capacity, heart function, and side effects helps refine therapy and support quality of life.

In summary, pulmonary hypertension involves elevated pressure in the lung circulation that places significant strain on the right side of the heart and reduces the body’s ability to transport oxygen efficiently. Understanding how it develops, the symptoms it can cause, and the approaches used to diagnose and treat it allows individuals, caregivers, and clinicians to work together more effectively in managing this challenging condition.